Literature DB >> 29767278

The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy.

Hans-Gert Bernstein1,2, Henrik Dobrowolny3, Bernhard Bogerts3, Gerburg Keilhoff4, Johann Steiner3.   

Abstract

The past decades have witnessed an explosion of knowledge on brain structural abnormalities in schizophrenia and depression. Focusing on the hypothalamus, we try to show how postmortem brain microscopy has contributed to our understanding of mental disease-related pathologic alterations of this brain region. Gross anatomical abnormalities (volume changes of the third ventricle, the hypothalamus, and its nuclei) and alterations at the cellular level (loss of neurons, increased or decreased expression of hypothalamic peptides such as oxytocin, vasopressin, corticotropin-releasing hormone, and other regulatory factors as well as of enzymes involved in neurotransmitter and neuropeptide metabolism) have been reported in schizophrenia and/or depression. While histologic research has mainly concentrated on neurons, little is currently known about the impact of non-neuronal cells for hypothalamus pathology in mental disorders. Their study would be a rewarding task for the future.

Entities:  

Keywords:  Depression; Histopathology; Hypothalamus; Neuropeptides; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29767278     DOI: 10.1007/s00441-018-2849-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  4 in total

Review 1.  Review of nanotheranostics for molecular mechanisms underlying psychiatric disorders and commensurate nanotherapeutics for neuropsychiatry: The mind knockout.

Authors:  Rajiv Kumar; Bhupender S Chhikara; Kiran Gulia; Mitrabasu Chhillar
Journal:  Nanotheranostics       Date:  2021-03-01

2.  Expression of vasopressin mRNA in the hypothalamus of individuals with a diagnosis of schizophrenia.

Authors:  Johannes R Busch; Christina Jacobsen; Niels Lynnerup; Jytte Banner; Morten Møller
Journal:  Brain Behav       Date:  2019-07-13       Impact factor: 2.708

3.  Perturbation of Ephrin Receptor Signaling and Glutamatergic Transmission in the Hypothalamus in Depression Using Proteomics Integrated With Metabolomics.

Authors:  Yu Wu; Zhenhong Wei; Yonghong Li; Chaojun Wei; Yuanting Li; Pengfei Cheng; Hui Xu; Zhenhao Li; Rui Guo; Xiaoming Qi; Jing Jia; Yanjuan Jia; Wanxia Wang; Xiaoling Gao
Journal:  Front Neurosci       Date:  2019-12-17       Impact factor: 4.677

Review 4.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.